The molecular basis of Celiac disease

Journal of Molecular Recognition

Volumn 16, Issue 5, 2003, Pages 333-336

  Koning, Frits ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Celiac disease; Gluten peptides; HLA DQ; Tissue transglutaminase

Indexed keywords

ANIMALS; CELIAC DISEASE; GLUTEN; HLA-DQ ANTIGENS; HUMANS; MODELS, BIOLOGICAL; PEPTIDES; TRANSGLUTAMINASES;

EID: 0141872931     PISSN: 09523499     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmr.641     Document Type: Conference Paper

References (21)

1. Arentz-Hansen H, Körner R, Molberg Ø, Quarsten H, Vader W, Kooy YMC, Lundin KEA, Koning F, Roepstorff P, Sollid LM, McAdam S. 2000. The intestinal T cell response to α-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J. Exp. Med. 191: 603-612.
2. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D. 1997. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat. Med. 3: 797-801.
3. Godkin A, Friede T, Davenport M, Stevanovic S, Willis A, Jewell D, Hill A, Rammensee HG. 1997. Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabtes susceptibility allele HLA-DQ8 (DQ3.2). Int. Immunol. 9: 905.
4. Kwok WW, Domeier ME, Raymond FC, Byers P, Nepom GT. 1996. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. J. Immunol. 156: 2171-2177.
5. Lundin KE, Scott H, Hansen T, Paulsen G, Halstensen TS, Fausa O, Thorsby E, Sollid LM. 1993. Gliadin-specific, HLA-DQ(α1*0501,β1* 0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J. Exp. Med. 178: 187-196.
6. Lundin KEA, Sollid LM, Anthonson D, Norén O, Molberg Ø, Thorsby E, Sjöström H. 1997. Heterogeneous reactivity patterns of HLA-DQ-restricted, small intestinal T cell clones from patients with celiac disease. Gastroenterology 112: 752.
7. Marsh MN. 1992. Gluten, major histocompatibility complex, and the small intestine. Gastroenterology 102: 330.
8. Molberg Ø, McAdam S, Körner R, Quarsten H, Kristiansen C, Madsen L, Fugger L, Scott H, Norén O, Roepstorff P, Lundin KEA, Sjöström H, Sollid LM. 1998. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut derived T cells in celiac disease. Nat. Med. 4: 713-717.
9. Papadopoulos G, Wijmenga C, Koning F. 2001. Interplay between genetics and the environment in the development of celiac disease: perspectives for a healthy life. J. Clin. Invest. 108: 1261-1266.
10. Rammensee HG, Friede T, Stevanovic S. 1995. MHC ligands and peptide motifs: first listing. Imunogenetics 41: 178-228.
11. Sjostrom H, Lundin KEA, Molberg Ø, Korner R, McAdam S, Anthonsen D, Quarsten H, Noren O, Roepstorff P, Thorsby E, Sollid LM. 1998. Identification of a gliadin T cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T cell recognition. Scand. J. Immnol. 48: 111-115.
12. Sollid LM, Markussen G, Ek J. 1989. Evidence for a primary association of coeliac disease to a particular HLA-DQ alpha/ beta heterodimer. J. Exp. Med. 169: 345-350.
13. Spurkland A, Ingvarsson G, Falk ES, Knutsen I, Sollid LM, Thorsby E. 1997. Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ(α1*0501, β1*02) or the HLA-DQ(α1*03, β1*0302) heterodimers. Tissue Antigens 49: 29.
14. Tighe MR, Hall MA, Barbado M. 1992. HLA class II alleles associated with celiac disease susceptibility in a southern European population. Tissue Antigens 40: 90-97.
15. Vader W, Kooy Y, van Veelen P, de Ru A, Harris D, Benckhuijsen W, Pena S, Mearin L, Drijfhout JW, Koning F. 2002a. The gluten response in children with recent onset celiac disease. A highly diverse response towards multiple gliadin and glutenin derived peptides. Gastroenterology 122: 1729-1737.
16. Vader W, de Ru A, Wal Y, van de Kooy Y, Benckhuijsen W, Mearin L, Drijfhout JW, van Veelen P, Koning F. 2002b. Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J. Exp. Med. 195: 643-649.
17. Vartdal F, Johansen BH, Friede T, Thorpe CJ, Stevanovic S, Eriksen JE, Sletten K, Thorsby E, Rammensee HG, Sollid LM. 1996. The peptide binding motif of the disease-associated HLA-DQ(α1*0501,β1*0201) molecule. Eur. J. Immunol. 26: 2764-2774.
18. van de Wal Y, Kooy YMC, Drijfhout JW, Amons R, Koning F. 1996. Peptide binding characteristics of the coeliac disease-associated DQ(α1* 0501,β1*0201) molecule. Immunogenetics 44: 246-253.
19. van de Wal Y, Kooy Y, Veelen van P, Pena S, Mearin L, Molberg Ø, Lundin L, Mutis T, Benckhuijsen W, Drijfhout JW, Koning F. 1998a. Small intestinal cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc. Natl Acad. Sci. USA 95: 10050-10054.
20. van de Wal Y, Kooy YMC, Veelen van P, Peña AS, Mearin ML, Papadopoulos GK, Koning F. 1998b. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J. Immunol. 161: 1585-1588.
21. van de Wal Y, Kooy YMC, Veelen van P, August SA, Drijfhout JW, Koning F. 2000. Glutenin is involved in the gluten-driven mucosal T cell response. Eur. J. Immunol. 29: 3133-3139.